Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
Biochimica Et Biophysica Acta|June 7, 2011
NMR structural study of the intracellular loop 3 of the serotonin 5-HT(1A) receptor and its interaction with calmodulinAngela Shuyi Chen, Young Mee Kim, Shovanlal Gayen, et al.Molecular Diversity|January 5, 2021
First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discoverySk Abdul Amin, Suvankar Banerjee, Samayaditya Singh, et al.RSC Medicinal Chemistry|May 11, 2026
A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: <i>in silico</i> design, synthesis, biological assessment and binding interaction analysisSamima Khatun, Venkatesh Muthukumar, Ambati Himaja, et al.European Journal of Pharmacology|September 18, 2021
Urea transporter and its specific and nonspecific inhibitors: State of the art and pharmacological perspectiveSudipta Nandi, Saptarshi Sanyal, Sk Abdul Amin, et al.FEMS Microbiology Letters|March 4, 2011
NMR solution structure of NBD94(483-502) of the nucleotide-binding domain of the Plasmodium yoelii reticulocyte-binding protein Py235Sandip Basak, Shovanlal Gayen, Jeya Kumar Ramalingam, et al.Bioorganic & Medicinal Chemistry|December 5, 2021
How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitorsDipayan Mondal, Sk Abdul Amin, Md Moinul, et al.Journal of Bioenergetics and Biomembranes|February 22, 2012
Subunit F modulates ATP binding and migration in the nucleotide-binding subunit B of the A(1)A(O) ATP synthase of Methanosarcina mazei Gö1Devanathan Raghunathan, Shovanlal Gayen, Anil Kumar, et al.Journal of Biomolecular Structure & Dynamics|May 7, 2019
Exploration of good and bad structural fingerprints for inhibition of indoleamine-2,3-dioxygenase enzyme in cancer immunotherapy using Monte Carlo optimization and Bayesian classification QSAR modelingSanskar Jain, Bhagwati Bhardwaj, Sk Abdul Amin, et al.Expert Opinion on Drug Discovery|January 23, 2024
Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agentsSamima Khatun, Sk Abdul Amin, Debasmita Choudhury, et al.Farmaco (Societa Chimica Italiana : 1989)|August 2, 2005
QSAR modeling on dopamine D2 receptor binding affinity of 6-methoxy benzamidesSoma Samanta, Bikash Debnath, Shovanlal Gayen, et al.Pageof 12